Skip to main content
logo
TME Pharma N.V. (EPA:ALTME)
France flag France · Delayed Price · Currency is EUR
0.0892
+0.0014 (1.59%)
Aug 21, 2026, 5:35 PM CET

TME Pharma Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----0.03
Revenue Growth
------5.71%
Gross Profit
-----0.03
Operating Income
-2.86-2.86-5.26-5.62-12.01-13.46
Net Income
-3.29-3.29-5.72-6.74-15.13-14.45
Earnings Per Share
-0.03-0.03-0.16-1.34-12.86-21.90
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.012.013.242.254.639.46
Total Debt
2.392.39-1.174.092.44
Net Cash (Debt)
-0.38-0.383.241.080.557.02
Net Cash Growth
--200.28%96.90%-92.19%-27.30%
Net Cash Per Share
-0.00-0.000.090.210.4710.63

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-3.42-3.42-4.63-5.64-12.14-12.38
Capital Expenditures
---0.02-0.02-0.02-0.01
Free Cash Flow
-3.42-3.42-4.65-5.65-12.16-12.4
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-----100.00%
Operating Margin
------40790.91%
Pretax Margin
------43793.94%
Profit Margin
------43793.94%
FCF Margin
------37560.61%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-4.114.114.114.114.11
PS Ratio
-----528.50